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 28 
Objectives. UK exercise referral schemes (ERSs) have been criticised for focusing too much on exercise 29 
prescription and not enough on sustainable physical activity (PA) behaviour change.  Previously, a 30 
theoretically-grounded intervention (Co-PARS) was co-produced to support long-term PA behaviour 31 
change in individuals with health conditions. The purpose of this study was to investigate the 32 
effectiveness of Co-PARS compared to a usual care ERS and no treatment for increasing 33 
cardiorespiratory fitness.  34 
Design. A three-arm quasi-experimental trial.  35 
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Setting. Two leisure centres providing a) Co-PARS, b) usual exercise referral care, and one no-1 
treatment control.  2 
Participants. 68 adults with lifestyle-related health conditions (e.g. cardiovascular, diabetes, 3 
depression) were recruited to Co-PARS, usual care, or no treatment. 4 
Intervention. 16-weeks of physical activity behaviour change support delivered at 4, 8, 12, and 18 5 
weeks, in addition to the usual care 12-week leisure centre access.  6 
Outcome measures. Cardiorespiratory fitness, vascular health, PA, and mental wellbeing were 7 
measured at baseline, 12 weeks, and 6 months (PA and mental wellbeing only). Fitness centre 8 
engagement (Co-PARS and usual care) and behaviour change consultation attendance (Co-PARS) were 9 
assessed. Following an intention-to-treat approach, repeated-measures linear mixed models were 10 
used to explore intervention effects. 11 
Results. Significant improvements in cardiorespiratory fitness (p=.002) and vascular health (p=.002) 12 
were found in Co-PARS compared to usual care and no-treatment at 12 weeks. No significant changes 13 
in PA or wellbeing at 12 weeks or 6 months were noted. Intervention engagement was higher in Co-14 
PARS than usual care, though this was not statistically significant. 15 
Conclusion. A co-produced PA behaviour change intervention led to promising improvements in 16 
cardiorespiratory and vascular health at 12 weeks, despite no effect for PA levels at 12 weeks or 6 17 
months.  18 
 19 
Trial registration: ClinicalTrials.gov: NCT03490747 20 
 21 
Keywords: Cardiovascular Health; Self-Determination Theory; Exercise Referral; Behaviour Change 22 
Intervention; Translational Research.  23 
 24 
 25 
 26 
 27 
Strengths and limitations of the study 28 
 This study advances the literature on exercise referral effectiveness by pragmatically evaluating a 29 
co-produced physical activity referral intervention, which was underpinned by multiple 30 
stakeholders and behaviour change theory.  31 
 The study documents the third phase of a novel and iterative approach which co-produced, 32 
piloted, and then evaluated (this study) a physical activity referral intervention that was deemed 33 
feasible to implement in practice.  34 
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 Objective and subjective measures provide insight into the potential effects for patient health.  1 
 It is not possible to directly attribute intervention effects to the phased co-production approach, 2 
although supported by the Medical Research Council.  3 
 A larger sample size is needed to substantiate findings.  4 
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Physical inactivity is the fourth leading cause of death worldwide and costs the UK an estimated £7.4 1 
billion annually, including £0.9 billion to the NHS alone[1]. Exercise referral schemes (ERSs) provide a 2 
promising framework to facilitate physical activity (PA) behaviour change in at-risk populations. 3 
Typically, UK ERSs consist of a referral from a healthcare professional to a 12-16-week tailored exercise 4 
programme provided by a qualified practitioner. 5 
There is inconsistent evidence as to the effectiveness of ERSs on PA behaviour, mental well-being, 6 
quality of life, and physical health outcomes [2–4]. More recently, however, promising effects of ERSs 7 
have been demonstrated in Wales [5], Sweden [6], and Spain [7] and a systematic review identified 8 
promising effects of UK ERSs on self-reported PA and cardiovascular health markers [8]. Prior and 9 
colleagues [9] demonstrated that for every 11 participants referred to a 24-week ERS, 1 participant 10 
went on to report achieving ≥90 min/week of PA at 12-months. For perspective, it is estimated that 11 
67-167 patients (categorised as <10% cardiovascular disease (CVD) risk)  need to receive statin 12 
treatment for 5 years to prevent one major vascular event [10]. Whilst we are not suggesting PA 13 
behaviour change is a comparable outcome to a serious clinical event, it is notable that replacing 30 14 
minutes of TV viewing time with PA across the UK population, could reduce premature mortality by 15 
5-15%, depending on activity intensity [11]. The majority of studies evaluating ERSs, however, have 16 
drawn on self-reported PA data and future studies employing device-based measures are needed to 17 
substantiate these observations.  18 
Despite recent promise for the effectiveness of ERSs [7–9,12], substantial heterogeneity exists in both 19 
design and delivery [13,14], reflecting varying assumptions on how best to promote health behaviour 20 
change [15,16]. This limits potential scalability of ‘successful’ ERSs. Traditionally, ERSs have focussed 21 
on short-term exercise prescription without appropriate evidence of effectiveness or underpinning of 22 
behaviour change theory [17]. A recent attempt to integrate behaviour change theory into an ERS [18] 23 
however, showed no advantage over a standard ERS at 12 weeks or 6 months. The authors noted 24 
considerable implementation challenges when training staff, such as work-related demands that may 25 
have reduced the importance of the theory-based training. It is plausible that delivery staff asked to 26 
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implement interventions designed by academics may lack ownership and feel less 1 
motivated/competent. One potential way to promote ownership and engagement might be to adopt 2 
a co-production approach, as a means of co-creating value across the public sector [19–21]. Though 3 
not a panacea, the involvement of practitioners, managers and service-users in co-production has 4 
potential to improve intervention relevance, fidelity, and effectiveness [22].  5 
Previously, a theoretically-grounded PA referral scheme (Co-PARS) was co-produced by academics, 6 
policy-makers, practitioners, and service-users [23] in Liverpool, UK, with a focus on supporting 7 
sustainable PA behaviour change. Liverpool is the 3rd most deprived local authority in England and 8 
has the 2nd highest proportion of Lower Super Output Areas (LSOAs) in the most deprived 10% 9 
nationally [24].  Interventional work with at-risk patients is therefore critical and is aligned with the 10 
concept of proportionate universalism [25]. Underpinned by self-determination theory [24], the co-11 
produced intervention differed from usual ERS care in its focus on PA behaviour change (rather than 12 
exercise prescription), and inclusion of frequent one-to-one consultations with exercise referral 13 
practitioners (compared to usual care which included formal contact at induction only).  A pilot of Co-14 
PARS [26] showed clinically meaningful improvements in cardiorespiratory fitness (CRF) and PA, 15 
although as we did not include a usual care control, it was unknown whether these effects were due 16 
to the fact participants were taking part in an ERS or due to the unique elements of Co-PARS.   17 
Furthermore, despite having very low CRF (<27.7 ml.kg-1.min-1) [26] we found 64% of the baseline pilot 18 
sample were meeting the PA guidelines [27] of at least 150 minutes moderate-intensity PA per week 19 
(measured objectively via accelerometry). This suggested CRF may be a more appropriate primary 20 
outcome measure than PA for this low-fit population (whilst changing PA behaviour was the focus of 21 
the intervention, a target health outcome of this behaviour change was improved CRF). The pilot also 22 
allowed the opportunity to investigate delivery processes, and we noted several areas that required 23 
refinement in preparation for a controlled trial. These refinements included, increasing the number 24 
of behaviour change consultations from four to five; enhanced focus on daily PA opportunities (rather 25 
than focussing on activities offered at the fitness centre); adapting staff timetables to promote 26 
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consistency of care and to allow participant one-to-one consultations to take place in a private room; 1 
and reducing practitioner paperwork. Building on our previous pilot work, the aim of the current study 2 
was to investigate the effectiveness of Co-PARS compared to a usual care ERS and a no-treatment 3 
control on change in cardiorespiratory fitness (CRF) at 12 weeks and PA and wellbeing at 6 months.   4 
METHODS 5 
Study Design 6 
A three-arm quasi-experimental trial involving: 1. Co-PARS (delivered at fitness centre A); 2. usual care 7 
ERS (delivered at fitness centre B); and 3. no-treatment control.  This paper reports trial outcomes 8 
(CRF, vascular health, PA, mental wellbeing) measured at baseline, 12 weeks, and 6 months (PA and 9 
mental wellbeing only). Additional data were collected to investigate psychosocial processes of 10 
change, intervention fidelity and cost-effectiveness; due to space limitations they are not considered 11 
in the present manuscript, but findings can be obtained on request from p.m.watson@ljmu.ac.uk. Full 12 
written consent was obtained from participants and the study was approved by NHS Research Ethics 13 
Committee (REC: 18/NW/0039 - Project: 238547) and registered on ClinicalTrials.gov (NCT03490747).  14 
Patient and Public Involvement 15 
The intervention was previously co-produced, piloted, and adapted with substantial service user input 16 
[23,26]. In summary, this process involved several iterative development workshop with 17 
commissioners, managers, service providers, service users, and researchers to develop a Co-PARS 18 
framework. This co-production process resulted in an intervention framework that was designed to 19 
be implemented within existing infrastructures. A subsequent pilot study explored the preliminary 20 
health impact and acceptability of Co-PARS. Findings from this pilot phase informed adaptations to 21 
Co-PARS that allowed for improved intervention feasibility, prior to conducting the present trial.  22 
Participants and Recruitment  23 
Inclusion criteria were the same for all three conditions (Co-PARS, usual care, no-treatment).  24 
Participants were eligible if aged ≥18 years with a health-related risk factor (e.g. hypertension, 25 
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hyperglycaemia, obesity) and/or health condition (e.g. diabetes, cardiovascular disease, depression) 1 
that may be alleviated by increasing PA levels. Participants with uncontrolled health conditions, severe 2 
psychological or neurological conditions were excluded. Participants for the Co-PARS and usual care 3 
arms were recruited from fitness centre A (Co-PARS) and fitness centre B (usual care) respectively 4 
(where they had been referred for exercise by a health professional). Reception staff at both centres 5 
provided study information and gained consent to pass participant details to the researcher. 6 
Participants for the no-treatment control were recruited via posters, electronic invitations, and email 7 
communications primarily at the university site.  Participants were not eligible for the no-treatment 8 
control if they were currently attending an exercise referral scheme. Interested participants for all 9 
groups were sent an information sheet and baseline data collection was arranged.  10 
Study Arms 11 
Intervention arm components are presented in Figure 1. 12 
Usual care exercise referral scheme (ERS – centre B). Usual care followed a standard ERS model of 12-13 
week subsidised access to a fitness centre (swimming, gym, group classes). Participants met an 14 
exercise referral practitioner for an initial, 1-hour induction (week 1) during which a 12-week exercise 15 
programme was provided for the participant. Any further contact with a practitioner was informal and 16 
opportunistic. This system was already in place and was considered usual care for the local area. 17 
Centre B was chosen as a comparison centre due to its similarity in referral numbers and socio-18 
economic make-up of the local population to centre A (where Co-PARS was being delivered). For 19 
example, based on areas within Liverpool ranked from 1 (most deprived) to 30 (least deprived), usual 20 
care ERS and Co-PARS were ranked respectively: 20th and 21st (income), 20th and 21st (employment), 21 
22nd and 24th (Education) and 10th and 11th (living environment).  22 
Co-produced PA referral scheme (Co-PARS – centre A) 23 
Participants received the same 12-week subsidised access to a fitness centre as usual care plus a series 24 
of one-to-one behaviour change consultations (60-minute induction followed by 30-minute 25 
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consultations at weeks 4, 8, 12 and 18). A log book was provided for each participant to set action 1 
plans, log progress and facilitate consultation discussions. Consultations were delivered by exercise 2 
referral practitioners in an autonomy supportive counselling style, drawing on the principles of self-3 
determination theory [28]. This additional support aimed to encourage habitual opportunities to 4 
increase PA as well as activities available at the fitness centre. A full descripion of the theoretical 5 
underpinning and behaviour change intervention components is available elsewhere [23]. 6 
Prior to the pilot of Co-PARS [26] practitioners received training in self-determination theory-based 7 
communication strategies led by a sport and exercise psychologist (last author [PMW]), involving a 8 
workshop, one-to-one sessions and follow-up group meetings.  Following the pilot, a further series of 9 
group meetings involving exercise referral practitioners and the research team were held to develop 10 
aspects of delivery that required refinement (as outlined in the introduction).  Full details of the 11 
training are available from p.m.watson@ljmu.ac.uk).     12 
No-treatment control (NTC). Participants received a lifestyle advice booklet only (offered to all study 13 
arms at baseline data collection), based on national guidance for PA, nutrition, smoking cessation and 14 
alcohol consumption.  15 
[INSERT FIGURE 1 SOMEWHERE HERE] 16 
 17 
Outcome measures 18 
Primary outcome: Cardio-respiratory fitness (CRF). Maximal oxygen consumption (VO2max-2) was 19 
estimated via the sub-maximal Astrand-Rhyming cycle ergometer protocol [29]. The protocol is a 20 
single-stage cycling test designed to elicit a steady-state heart rate over a period of ~6 minutes.  21 
Accelerometer-derived PA. Tri-axial ActiGraph GT3x accelerometers (ActiGraph, Pensacola, FL, USA) 22 
measured PA for 7 days, which have been validated in a comparable population [30]. Raw triaxial 23 
acceleration values were converted into an omnidirectional measure of acceleration, referred to as 24 
Euclidian norm minus one [31]. Minimum wear time was 10 hours per day and 3 days per week 25 
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including one weekend day [32]. The R package GGIR [31] facilitated extraction of user-defined 1 
acceleration thresholds: 5.9 to 69.1 mg for light-intensity PA [33], 69.1 to 258.7 mg as moderate and 2 
>258.7 mg as vigorous-intensity PA [34]. 3 
Vascular health. Our previous work has demonstrated carotid artery reactivity (CAR) may be a 4 
promising outcome variable  to assess in PA interventions for at-risk populations [35]. Further, 5 
endothelial function may provide prognostic value beyond that of traditional risk factors [36] with an 6 
increase of 1% in brachial artery flow-mediated dilation (FMD) associated with a 12-15% lower risk of 7 
CV events [33,34]. FMD and CAR were measured using ultrasound techniques [35]. Both techniques 8 
measure vascular endothelial function and have independently predicted future risk of cardiovascular 9 
events in humans [36,37]. Blood pressure was measured in the supine position using an automated 10 
blood pressure device (Omron Healthcare UK Limited, Milton Keynes, UK).  11 
Anthropometric measures. Since obesity is a critical risk factor for poor health and cardiovascular 12 
disease, anthropometric variables were measured to investigate potential intervention effects on 13 
body mass.  Waist-to-height ratio is a stronger predictor of early health risk than Body Mass Index 14 
(BMI) alone [38], therefore we collected both BMI (mass in kg / stature in m2) and waist-to-height 15 
ratio (waist circumference / stature).  16 
Mental wellbeing. As PA is known to enhance mental wellbeing [39] and clinical populations are more 17 
susceptible to mental ill-health [40], it was important to identify whether Co-PARS led to any changes 18 
in mental health (positive or negative). Mental wellbeing was measured using the 14-item Warwick-19 
Edinburgh Mental Well-being Scale (WEMWBS; [41], which asks participants to rate their 20 
psychological wellbeing (e.g. “I’ve been feeling cheerful”) over the previous 2 weeks (measured on a 21 
likert scale of 1 (none of the time) to 5 (all of the time)). 22 
Fitness centre engagement (Co-PARS and usual care only). The number of occasions participants 23 
attended the fitness centre between baseline and 12 weeks (weekly attendance) and 12 weeks to 6 24 
months (monthly attendance) was obtained from computerised attendance records.  When 25 
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measuring intervention engagement it was deemed inappropriate to calculate the mean number of 1 
sessions per week, since this could exaggerate the engagement of individuals who attended with 2 
high frequency in the early weeks then dropped out (when compared with individuals who attended 3 
moderately but consistently for the full 12 weeks). Therefore a formula was used to calculate a 4 
percentage for ‘12-week engagement’ (based on the recommended bi-weekly attendance ): 5 
 6 
 7 
 8 
 9 
 10 
This formula took into account both frequency and consistency of attendance to yield a percentage 11 
score that ranged from 0% (no attendance) to 120% (attendance of three or more times per week 12 
for the whole 12 weeks).    13 
Monthly attendance post-12 weeks was calculated as a mean attendance across months 4 to 6, 14 
therefore did not take consistency of attendance into account.     15 
Behaviour change consultation attendance (Co-PARS only).  The number of consultations offered and 16 
attended were measured by exercise referral practitioners at induction, 4, 8, 12, and 18 weeks. 17 
Sample size 18 
Sample size was determined to detect a meaningful difference in CRF at 12 weeks based on our pilot 19 
results [26]. To detect a difference of 2 ml.kg-1min-1 between Co-PARS and usual care, 42 participants 20 
were required per arm (f= .25, p= .05, power = .80). To detect a difference of 3.2 ml.kg-1min-1 between 21 
the intervention arms and the no-treatment control, 17 participants were required for the no-22 
treatment control (f= .5, p= .05, power = .80). Thus, a total sample of 101 participants were required. 23 
Statistical analyses 24 
((n1*0.5) + (n2) + (n3*1.2)) 
12 
 
* 100 
n1 = number of weeks in which participant attends once only 
n2 = number of weeks in which participant attends twice 
n3 = number of weeks in which participant attends three or more times  
 
11 | P a g e  
 
An intention-to-treat approach was used assuming no change in non-respondents (last observation 1 
carried forward) to produce a conservative estimate of intervention effects. Delta changes (∆) from 2 
pre- to post-intervention were calculated for each group and entered as the dependent variable in 3 
repeated measures linear mixed model analyses.  A random intercept model was used with fixed 4 
effects for study arm (Co-PARS, usual care ERS, no-treatment control) and time (baseline-to-week-12 5 
change, week-12-to-6-month change, and baseline-to-6-month change) and participants included as 6 
random effects. Least squared difference (LSD) was used for post hoc testing. Testing for baseline 7 
differences to identify covariates was avoided, as this method has been demonstrated to inflate bias, 8 
instead pre-intervention was entered into the model as a covariate. Furthermore, all linear mixed 9 
model analyses were repeated with age and employment as covariates as a comparison to the results 10 
presented in this study (with baseline score as a covariate) due to their known prognostic value. Using 11 
age and employment as covariates resulted in no change in inferences presented in this study. One-12 
way ANOVAs were used to compare baseline values between intervention arms. Fitness centre 13 
engagement was determined as described above. Behaviour change consultation attendance is 14 
presented descriptively. For non-normally distributed data, median and interquartile range is 15 
presented and within group median change was calculated via Wilcoxon signed-rank tests. 16 
RESULTS 17 
Participants. 68 participants provided baseline data, 56 of whom provided 12-week data, and 58 of 18 
whom provided 6-month data (figure 2).   19 
Baseline characteristics (table 1). No significant differences were noted between arms for age, sex, 20 
ethnicity, BMI, referral reason, or accelerometer-derived PA levels (p>.05). Full-time employment 21 
status (p=.001) and CRF (p=.015) were significantly higher in the control compared to usual care and 22 
Co-PARS. Smoking status was significantly higher in usual care compared to Co-PARS and control 23 
(p=.010). Mental wellbeing was significantly lower in Co-PARS compared to control (p=.023).  24 
 25 
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[INSERT FIGURE 2 SOMEWHERE HERE] 1 
 2 
 3 
 4 
 5 
Baseline-to-12-Week effects 6 
Table 1. Baseline characteristics presented as Mean  SD or % (n) of group. 
 Co-produced PA 
referral 
(n=33) 
Usual care 
ERS  
(n=19) 
No-treatment 
control  
(n=16) 
Between 
arm  
p-value 
Age (years) 57  12  53  16 48 ± 15 p=.319  
Female (% of sample) 58 (19) 47 (9) 56 (9) p=.774 
White British (% of sample) 82 (27) 95 (18) 75 (12) p=.132 
Full-time employment (% of sample) 18 (6) 26 (5) 62 (10) p=.001 
Never smoked (% of sample) 73 (24) 37 (7) 81 (13) p=.002 
Body mass index (kg/m2) 31  7 33  6 29 ± 6 p=.226 
Systolic blood pressure (mmHg) 131  11 138  18 123 ± 12 p=.010 
Primary referral reason /  health concern (control)   p=.132 
Cardiometabolic (% of sample) 67 (22) 43 (8) 62 (10) - 
Cancer (% of sample) 6 (2) 5 (1) 6 (1) - 
Mental Health (% of sample) 18 (6) 26 (5) 19 (3) - 
Musculoskeletal (% of sample) 9 (3) 26 (5) 13 (2) - 
Comorbidity (% of sample)  85 (28)  100 (19)  81 (13) p=.166 
Meeting the PA guidelines (% of 
sample)* 
73 (22) 71 (10) 93 (13) p=.223 
P-values represent between arm baseline effects. There was no between arm effect for referral reason, thus no between arm p-values are provided for referral reason 
sub groups.  
*Chief Medical Officers’ 2019 physical activity guidelines: 150 minutes of moderate-intensity physical activity per week.  
13 | P a g e  
 
Raw outcome values are presented for baseline, week 12, and 6 months in Table 2. There was a 1 
significant effect for study arm in baseline-to-12-week change in CRF (p=.002). Post hoc testing 2 
revealed a significantly higher CRF change in Co-PARS (2.4) compared to the ERS (0.3; p=.021) and 3 
control (-0.6; p=.001), but no difference between the ERS and control (p=.314). A significant effect for 4 
study arm was found in change in FMD% (p=.002), with FMD% change significantly higher in Co-PARS 5 
(2.4) compared to control (-1.1; p=.001) but not the ERS (0.8; p=.099). The change in FMD% was not 6 
significantly different between the ERS and control (p=.71). No statistically significant study arm 7 
effects were noted for changes in CAR%, blood pressure, resting heart rate, anthropometric measures, 8 
PA or WEMWBS at 12 weeks (p>.05).  9 
Baseline-to-6-month effects 10 
No statistically significant study arm effects were noted for change in WEMWBS or PA at 6 months 11 
(p>.05).  12 
Fitness centre engagement (Co-PARS and usual care ERS) and consultation attendance (Co-PARS 13 
only).  14 
Table 3 reports the participant fitness centre engagement data for the Co-PARS and usual care ERS. 15 
Although not statistically significant, Co-PARS engagement was 9% higher, participants attended the 16 
fitness centre on average 3 times more per month, and 23% more participants were attending the 17 
fitness centre beyond 6-months follow-up compared to usual care. Co-PARS behaviour change 18 
consultation attendance is reported in Table 4. 19 
 20 
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Table 2. Cardiometabolic health outcomes and PA levels at baseline, 12 weeks, 6 months, and between arm baseline-to 12-week or 6-month 
effect.  All variables are presented as Mean  SD. 
 Co-PARS Usual Care ERS No-Treatment Control  
 Baseline Week 12 6 Month Baseline Week 12 6 Month Baseline Week 12 6 Month 
Between arm effect p-
value(a) 
Fitness (n=56) 
CRF  ml.kg.-1min-1 22.27 24.67 - 23.36.6 23.67 - 29.69.2 28.98.7 - p=.002 
Physical Activity 
GT3x (n= 61) Mins.day        
Light intensity  9052 9864 10775 9836 9331 158145 9037 10133 8640 p=.332 
Moderate intensity  4432 4229 4233 4328 4330 5555 6031 6524 5421 p=.260 
Vigorous intensity  13 12 12 12 11 12 24 23 38 p=.108 
Vascular Ultrasound (n=64) 
CAR%  1.72.7 2.82.2 - 2.71.8 3.92.8 - 2.52.7 1.72.7 - p=.073 
CAR Baseline cm 0.690.07 0.690.06 - 0.690.08 0.70.09 - 0.650.07 0.640.06 - p=.130 
FMD% 4.42.3 6.82.7 - 4.22 52.1 - 6.22.1 5.22.8 - p=.002 
FMD Baseline  cm 0.390.07 0.380.06 - 0.390.09 0.41 0.08 - 0.380.08 0.370.06 - p=.728 
Cardiometabolic (n=68) 
BMI kg.m2 317 307 - 336 326 - 296 296 - p=.323 
WHR 629 6110 - 648 638 - 569 569 - p=.261 
SBP mmHg 13111 12712 - 13818 13215 - 12312 11813 - p=.937 
DBP  mmHg 737 718 - 739 7111 - 7211 6810 - p=.584 
RHR bpm 7010 6510  7012 6811  6612 639  p=.540 
Mental Wellbeing (n=68) 
WEMWBS 469 5110 4810 4910 5211 5013 539 569 5310 p=.796 
 Co-PARS, Co-produced PA referral scheme; ERS, Exercise referral scheme; CRF, Cardiorespiratory Fitness; GT3x, Accelerometer; CAR, Carotid artery reactivity; FMD, Flow-mediated dilation; BMI, Body Mass Index; WHR, 
Waist-to-Height ratio;  SBP, Systolic blood pressure; DBP, Diastolic blood pressure; RHR, Resting heart rate, WEMWBS, Warwick-Edinburgh Mental Wellbeing Scale 
a F-statistic for between arm baseline-to-6-month change or baseline-to-week 12 change if variable not collected at 6 months. 
Missing data was due to inability to complete the CRF test (n=12), inability to complete the vascular ultrasound protocols (n=4), and insufficient accelerometer wear time or non-return (n=7).  
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Table 3. Fitness centre engagement. 
  Co-PARS 
(n=33) 
Usual Care 
(n=19) 
Between centre difference 
 
% Engagementa  (Mean  SD) 42±29 33±27 p=.267 
Number of fitness centre visits (per person  
per month) week 12 to 6 months (Med, IQR) 
3(0-14) 0 (0-1) p=.072 
% of baseline sample who attended fitness 
centre at least once beyond 6 months (% of 
sample, n) 
39 (13) 16 (3) p=.101 
aBased on the formula (((n1*0.5)+(n2)+(n3*1.2))/12) * 100; n1=number of weeks in which participant attends once only; n2=number of weeks in which 
participant attends twice; n3=number of weeks in which participant attends three or more times.  aEngagement;.based on a recommended attendance 
of twice weekly, a formula was used to calculate a percentage for “12-week engagement”, which took into account both frequency and consistency of 
attendance (see methods).  
Table 4. Co-PARS behaviour change consultation attendance (based on baseline sample of 33 
participants). 
Consultation % Booked (n) % Attended (n) 
Induction 91(30) 93(28) 
Week 4 82(27) 78(21) 
Week 8 67(22) 91(20) 
Week 12 64(21) 81(17) 
Week 18 55(18) 50(9) 
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DISCUSSION 1 
This was the first study to investigate the effectiveness of a theoretically-grounded, co-produced PA 2 
referral scheme (Co-PARS) compared to a usual care ERS and no treatment. Despite challenges in 3 
recruitment that meant the study was statistically underpowered, the findings demonstrated 4 
significant and clinically meaningful improvements in CRF and vascular health in Co-PARS compared 5 
to the usual care and no treatment. No statistically significant effects were noted for accelerometer-6 
derived PA levels or mental wellbeing at 12-weeks or 6-months.  7 
The effect of usual care ERSs compared to theoretically-grounded interventions on CRF has not been 8 
previously explored. We observed a significant increase in CRF in Co-PARS compared to usual care and 9 
a no-treatment control. According to values reported by Clausen et al. [42] both Co-PARS (22 ml.kg.-10 
1min-1) and usual care (23 ml.kg.-1min-1) participants were below the lower limit of ‘healthy’ (27.7 11 
ml.kg.-1min-1) for baseline CRF [43]. As low CRF is associated with a substantially elevated risk of all-12 
cause mortality [43], the magnitude of change demonstrated in Co-PARS (2.4 ml.kg.-1min-1) may be 13 
clinically meaningful. For example, in at-risk populations, relatively small magnitudes (≤1 ml.kg.-1min-14 
1) have been shown to significantly reduce clustered cardiometabolic risk [44]. Thus, Co-PARS was 15 
effective at improving CRF in individuals with low CRF by a clinically meaningful amount. 16 
Promising improvements in vascular health were also noted in the Co-PARS group, with brachial artery 17 
FMD significantly improved compared to usual care and control arms. Although CAR was not 18 
statistically different between arms, both Co-PARS and usual care demonstrated a potentially 19 
meaningful within-arm improvement compared with no treatment, which exhibited a deterioration in 20 
vascular health. Such improvements in vascular measures may have prognostic implications. For 21 
example, a 1% increase in FMD has been suggested to reduce the future risk of CVD events by 13% 22 
[36]. 23 
Despite low baseline CRF, a substantial percentage of Co-PARS (73%) and usual care (71%) participants 24 
were meeting the Department of Health [45] guidelines of 150 minutes of moderate-intensity PA per 25 
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week. We observed a similar finding in our pilot [26] and subsequently raised the question as to the 1 
use of PA guidelines to assess eligibility for ERSs (NICE, 2014), as it appears from our data that 2 
individuals classified as “physically active” can still be very unfit and therefore can benefit from ERSs 3 
in terms of improved fitness and cardiometabolic health. A further discrepancy was noted in the lack 4 
of change in PA levels in Co-PARS, despite improved CRF. It is possible measurement issues 5 
contributed to this discrepancy. Accelerometers can measure certain types of PA such as walking, 6 
running, and stair climbing [46]. They may not, however, sufficiently identify activities typical of an 7 
ERS delivered within a fitness centre environment (e.g. cycling, resistance training, circuits, 8 
swimming). Given Co-PARS had higher (albeit non-significant) fitness centre engagement compared 9 
to usual care, it is possible PA changes occurred that were not detected by the accelerometry data. 10 
Consideration therefore needs to be given to the appropriateness of accelerometers to measure PA 11 
in ERSs.  Alternative methods such as heart-rate monitors combined with self-report data may be 12 
worthy of consideration, although further work would be required to develop standardized data 13 
collection and analysis protocols (taking into account the limitations of each of these methods if used 14 
in isolation [47]).  Researchers are therefore urged to consider CRF as a primary outcome in ERSs until 15 
appropriate alternative methods of measuring PA behaviour are developed. Ultimately, it is not clear 16 
why the increase in fitness occurred without a corresponding change in PA and further research is 17 
required to elucidate the relationship between PA and fitness in this population.  18 
In addition to physiological health outcomes, we found baseline mental wellbeing to be below the 19 
national average (score of 50) in both Co-PARS (46) and usual care (49), but not the control (53) [48]. 20 
Despite no significant between-group effect for mental wellbeing, within-group changes at 12 weeks 21 
were deemed clinically meaningful for Co-PARS (5) and usual care (3) but not in the no treatment 22 
control. It is notable that the post-intervention magnitude of change observed in mental wellbeing for 23 
Co-PARS (5) was larger than that observed in a meta-analysis encompassing >23,000 participants 24 
across 13 different ERSs (3), which were comparable in nature to the usual care ERS in this study [49]. 25 
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From the 6-month data it appeared the scheme was not effective at promoting sustained PA behaviour 1 
change or mental wellbeing improvements. It must be noted, however, that the wellbeing levels were 2 
still higher than baseline and even small magnitudes of change (1-3) may be meaningful in clinical 3 
populations [50]. As discussed earlier, it may be that measuring PA using the methods described in 4 
this study prevented the identification of activities typical of a fitness centre environment. This notion 5 
is supported by the post-week-12 attendance data, which highlighted Co-PARS participants were 6 
regularly attending the fitness centre whereas the usual care participants were not. Challenges of 7 
maintaining sustained health outcomes post-ERSs have been highlighted elsewhere [3]. And whilst a 8 
recent systematic review reported longer length schemes (>20 weeks) may be more effective than 9 
shorter schemes [8], the four long ERSs (20-26 weeks) collected pre-post data only. Thus we do not 10 
know if longer length ERSs result in enhanced health outcomes post intervention compared with 11 
shorter schemes. To determine if longer length schemes are indeed more effective, longer-term 12 
follow-up data collection is required, ideally at 6 and 12 months post intervention [51].  13 
Through a phased approach we have assessed the effectiveness of Co-PARS resulting from several 14 
years of co-production. Whilst the effects of co-production are difficult to isolate, a comparison of 15 
results at different stages of intervention refinement suggests the phased development approach had 16 
some positive effects. Unpublished engagement data from centre A in 2014-2015 (when the centre 17 
was running a usual care ERS) shows that engagement improved after the introduction of Co-PARS 18 
(42% vs 28% in 2014-2015), whereas engagement reduced in the usual care centre over the same 19 
period (32% vs 37% in 2014-2015).  Furthermore, consultation attendance for Co-PARS in the current 20 
study was substantially higher than in our previous pilot (54% attended induction plus ≥3 behaviour 21 
change consultations, vs 9% in the pilot [26]), which may have been a reflection of refinements made 22 
to the intervention after the pilot (e.g. improved focus on holistic PA, improved monitoring 23 
procedures, improved continuity of instructors). These improvements in engagement highlight the 24 
importance of allowing time for complex interventions to develop [52], and are particularly promising 25 
given the effectiveness of ERSs are highly dependent on participant adherence [5,21]. Furthermore, 26 
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this study has demonstrated how investing in the “bottom-up” development of an intervention can 1 
lead to an effective and sustainable model. We therefore support the arguments of Rutter and 2 
colleagues [53] in that a shift in thinking is needed, instead of asking whether an intervention works 3 
to fix a problem, researchers should aim to identify if and how it contributes to reshaping a system in 4 
a favourable way. As such, we propose the co-production and implementation process may be as 5 
important as the scheme content itself. 6 
Methodological considerations 7 
This is the first known study to investigate the effectiveness of a co-produced PA referral scheme (Co-8 
PARS) in comparison to usual care and a no-treatment control. Our novel approach addresses an 9 
important gap in the sport and exercise medicine literature [54], in that we employed rigorous 10 
laboratory-based instruments to measure  health outcomes that can be achieved through an 11 
ecologically valid, “real-world” intervention. We observed a very high retention at 6-month follow up, 12 
which may be due in part to the fact many of the participants were retired (and therefore may have 13 
more available time). It is possible also that the high retention was facilitated by the co-production 14 
process, which involved ongoing relationships between the research and delivery teams (and 15 
therefore helped with the logistics of returning accelerometers for the co-PARS and usual care 16 
groups). Whilst this paper highlights many strengths of co-production, we do not wish to present co-17 
production as a panacea [19] and it is important potential challenges and costs are considered prior 18 
to undertaking such an approach [21,22]. 19 
We must acknowledge some limitations of the study.  Whilst there is a need for high-quality RCTs of 20 
theoretically informed approaches to PA behaviour change [3],  several pragmatic reasons meant an 21 
RCT approach was not appropriate for the present study. Firstly, it was important participants could 22 
choose the most convenient fitness centre. Secondly, it was important we continued work with the 23 
same fitness centre and staff (following co-production [23] and pilot [26] phases) in order to develop 24 
the intervention to the point where it was deemed to have a worthwhile effect [52]. A pragmatic 25 
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research approach was therefore deemed most appropriate to evaluate Co-PARS with high ecological 1 
validity. Pragmatic constraints (e.g. fitness centre refurbishments, staff illness) did however mean the 2 
required sample size was not achieved, thus inferences of effectiveness need to be taken with caution. 3 
This is particularly true for the PA data, where the relatively high variability (compared with CRF) may 4 
have contributed to the lack of change observed in PA in this study. It is recommended future work 5 
considers pragmatic risks and contingencies when planning recruitment and plans sufficient time to 6 
cope with recruitment delays. For pragmatic reasons, not all outcomes were collected at 6-months 7 
follow-up and further research is needed to collect long-term, objective health data following PA 8 
referral schemes.  Finally, it must be noted that while the trial registration appears to be retrospective 9 
(April 6th 2018), the initial submission was several months prior to this (January 11th 2018).  Final sign-10 
off was delayed due to capacity issues within the research team.    11 
CONCLUSION 12 
A co-produced, theoretically-grounded PA referral scheme (Co-PARS) led to improved CRF and 13 
vascular health in at-risk individuals when compared to usual care and no treatment. In addition, 14 
clinically meaningful improvements in vascular health and mental wellbeing were observed at 12-15 
weeks in both Co-PARS and usual care, but not the no treatment control group. Of note, PA remained 16 
unchanged at 12-weeks and 6-months follow-up. Adopting a phased approach has enabled multi-17 
stakeholder input and ongoing intervention refinement, resulting in an intervention that showed 18 
promising effects on engagement and clinically meaningful improvements to participant health.   19 
  20 
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Figure Legends 1 
Figure 1. ‘PaT Plot’ describing intervention arm components.[55]  2 
Figure 2. Participant flow diagram within the three study arms (March 2018-January 2019).  3 
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